本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kiniksa Pharmaceuticals Ltd.

79.24
-0.5400-0.68%
盘前:79.640.3964+0.50%06:19 EDT
成交量:34.09万
成交额:2,716.71万
市值:61.83亿
市盈率:80.04
高:80.99
开:80.00
低:78.82
收:79.78
52周最高:82.94
52周最低:35.20
股本:7,802.40万
流通股本:3,994.15万
量比:0.86
换手率:0.85%
股息:- -
股息率:- -
每股收益(TTM):0.9900
每股收益(LYR):0.7500
净资产收益率:14.04%
总资产收益率:8.05%
市净率:9.45
市盈率(LYR):105.65

数据加载中...

2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/29

重要事件披露

Form 8-K - Current report
2024/10/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/10/08

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/08

重要事件披露

Form 8-K - Current report
2024/09/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/25

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/23

摘牌通告

Form 15-15D/A - Suspension of duty to report [Section 13 and 15(d)]: [Amend]
2024/07/23

重要事件披露

Form 8-K - Current report
2024/07/02

SEC问询函

Form CORRESP - Correspondence
2024/06/28

摘牌通告

Form 15-15D - Suspension of duty to report [Section 13 and 15(d)]
2024/06/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments